At the sixth annual Russian Pharma Awards 2017, Polyoxidonium, a Russian combination product that is an immunomodulator, detoxifier, and antioxidant, took the prize for «Product of choice for treating and preventing acute viral respiratory infection in children».

Boehringer Ingelheim has concluded phase one of their localization effort aimed at manufacturing their innovative thrombolytic medicines in Russia: the first batches of Metalyse (tenectaplase) for acute heart attack treatment were produced at NPO Petrovax Pharm facilities.

By the end of 2019, the companies intend to complete the transfer of technologies and to launch full-cycle production of innovative thrombolytic medicines at Petrovax Pharm’s production facility in the Moscow Region.

Vladimir Potanin, the owner and founder of Interros Group, one of the largest private investment companies in Russia, has completed acquisition of a controlling stake in Petrovax Pharm. For more details please visit www.petrovax.com

Reconstruction of the cargo terminal will give the ability to handle up to 45 pallets at the same time (a pallet is an aluminum plate with cargo weighting up to 2,6 tons; it is used to transfer goods from one plane to another without reassembly) in compliance with all necessary conditions of paperwork support. As a result cargo turnover of the terminal will reach 60-80 thousand tons annually. In case of increase of traffic flow, for example because of implementation of the “Open sky for cargo” project,  additional modernization will allow to handle up to 200 transfer pallets at the same time.